Edition:
India

Indivior PLC (INDV.L)

INDV.L on London Stock Exchange

48.56GBp
17 May 2019
Change (% chg)

-4.50 (-8.48%)
Prev Close
53.06
Open
52.70
Day's High
53.20
Day's Low
45.66
Volume
8,241,354
Avg. Vol
5,822,375
52-wk High
504.60
52-wk Low
20.98

Select another date:

Thu, May 9 2019

Indivior signs deal to sell schizophrenia drug in Canada

British drugmaker Indivior Plc on Thursday signed a licensing agreement with HLS Therapeutics Inc for the sale of its schizophrenia drug Perseris in Canada.

Indivior signs deal to sell schizophrenia drug in Canada

British drugmaker Indivior Plc on Thursday signed a licensing agreement with HLS Therapeutics Inc for the sale of its schizophrenia drug Perseris in Canada.

Indivior signs deal to sell schizophrenia drug in Canada

May 9 British drugmaker Indivior Plc on Thursday signed a licensing agreement with HLS Therapeutics Inc for the sale of its schizophrenia drug Perseris in Canada.

UPDATE 3-Indivior's Suboxone decline slower than feared as company bets on new opioid drug

* Stock closes up 5.2 percent (Adds graphics, CFO comment, details on DoJ investigation)

Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

(This April 10 story refiles to fix scrambled syntax in paragraph five)

Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

British drugmaker Indivior Plc lost nearly three-quarters of its share value on Wednesday and former parent Reckitt Benckiser also fell following U.S. criminal charges accusing Indivior of illegally increasing prescriptions for its opioid addiction treatment Suboxone.

REFILE-UPDATE 6-Indivior shares plummet, Reckitt hurt on U.S. charges over opioid prescriptions

* Indivior charged in the United States with conspiracy, fraud

U.S. indicts Indivior over Suboxone opioid treatment marketing

The U.S. Justice Department announced on Tuesday the indictment of Indivior Plc and a subsidiary on charges they engaged in an illegal scheme to boost prescriptions of the film version of its opioid addiction treatment Suboxone.

UPDATE 3-U.S. indicts Indivior over Suboxone opioid treatment marketing

April 9 The U.S. Justice Department announced on Tuesday the indictment of Indivior Plc and a subsidiary on charges they engaged in an illegal scheme to boost prescriptions of the film version of its opioid addiction treatment Suboxone.

U.S. indicts Indivior over Suboxone opioid treatment marketing

The U.S. Justice Department on Tuesday announced the indictment of Indivior Plc and a subsidiary on charges they engaged in an illegal scheme to boost prescriptions of the film version of its opioid addiction treatment Suboxone.

Select another date: